Tesla delivered 201,250 electric vehicles in the second quarter, just a bit short of Wall Street estimates of 207,000 vehicles, despite a global computer chip shortage that hobbled the auto industry.
The sales figures surpassed first-quarter sales of 185,000 and put Tesla towards doubling last year's annual deliveries of close to 500,000.
The number of deliveries could vary by up to 0.5 percent or more as Tesla only counts deliveries already transferred to the customer with the correct paperwork.
Sales in the second quarter more than doubled from April to June last year when Tesla and other automakers were forced to close factories for much of the quarter due to the pandemic.
Models 3 and Y were the most popular with Tesla selling 199,360 units of those in the second quarter. It was followed by Models S and X with 1,890 delivered.
The Palo Alto, California-based carmaker produced 206,421 vehicles for the quarter, including 2,340 of the Models S and X.
Wedbush analyst Daniel Ives wrote that 195,000 Model 3 and Y deliveries could give Tesla the potential to hit 900,000 in annual sales this year.


Australia GDP Beats Forecast, Boosting RBA Rate Hike Bets
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses
Asian Stocks Tumble as Oil Surge Fuels Rate Hike Fears
Bessent Urges Japan on Fiscal Discipline, BOJ Rate Hikes
Australia Current Account Deficit Widens to A$27.2 Billion
Shein Shares Drop 5% After Weak Hong Kong IPO Debut
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall
India Manufacturing Growth Slows to Five-Year Low in August
South Korea Unveils Record $597 Billion 2027 Budget to Boost AI and Chips
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates
Yen Extends Gains as BOJ Rate Hike Bets Rise
GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO
Shein Shares Slide 9% in Hong Kong IPO Debut
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability
Trump Secures Drug Pricing Deals With Nine Pharma Companies
CATL Shares Fall as Hungary Plant Faces Safety Halt 



